Outset Medical Statistics
Total Valuation
Outset Medical has a market cap or net worth of $77.88 million. The enterprise value is -$2.08 million.
Important Dates
The last earnings date was Monday, November 10, 2025, after market close.
| Earnings Date | Nov 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Outset Medical has 18.15 million shares outstanding. The number of shares has increased by 237.60% in one year.
| Current Share Class | 18.15M |
| Shares Outstanding | 18.15M |
| Shares Change (YoY) | +237.60% |
| Shares Change (QoQ) | +0.23% |
| Owned by Insiders (%) | 1.97% |
| Owned by Institutions (%) | 67.30% |
| Float | 12.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.41 |
| Forward PS | 0.60 |
| PB Ratio | 0.55 |
| P/TBV Ratio | 0.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.09, with a Debt / Equity ratio of 0.69.
| Current Ratio | 7.09 |
| Quick Ratio | 5.65 |
| Debt / Equity | 0.69 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.26 |
Financial Efficiency
Return on equity (ROE) is -92.33% and return on invested capital (ROIC) is -17.71%.
| Return on Equity (ROE) | -92.33% |
| Return on Assets (ROA) | -15.25% |
| Return on Invested Capital (ROIC) | -17.71% |
| Return on Capital Employed (ROCE) | -29.00% |
| Revenue Per Employee | $339,178 |
| Profits Per Employee | -$248,023 |
| Employee Count | 354 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 1.35 |
Taxes
In the past 12 months, Outset Medical has paid $619,000 in taxes.
| Income Tax | 619,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -60.59% in the last 52 weeks. The beta is 1.97, so Outset Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.97 |
| 52-Week Price Change | -60.59% |
| 50-Day Moving Average | 12.35 |
| 200-Day Moving Average | 14.02 |
| Relative Strength Index (RSI) | 16.77 |
| Average Volume (20 Days) | 730,523 |
Short Selling Information
The latest short interest is 1.73 million, so 9.52% of the outstanding shares have been sold short.
| Short Interest | 1.73M |
| Short Previous Month | 1.95M |
| Short % of Shares Out | 9.52% |
| Short % of Float | 14.30% |
| Short Ratio (days to cover) | 5.96 |
Income Statement
In the last 12 months, Outset Medical had revenue of $120.07 million and -$87.80 million in losses. Loss per share was -$7.60.
| Revenue | 120.07M |
| Gross Profit | 45.32M |
| Operating Income | -69.54M |
| Pretax Income | -87.18M |
| Net Income | -87.80M |
| EBITDA | -64.67M |
| EBIT | -69.54M |
| Loss Per Share | -$7.60 |
Full Income StatementBalance Sheet
The company has $178.64 million in cash and $98.68 million in debt, giving a net cash position of $79.96 million or $4.40 per share.
| Cash & Cash Equivalents | 178.64M |
| Total Debt | 98.68M |
| Net Cash | 79.96M |
| Net Cash Per Share | $4.40 |
| Equity (Book Value) | 142.37M |
| Book Value Per Share | 7.78 |
| Working Capital | 227.92M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$53.29 million and capital expenditures -$618,000, giving a free cash flow of -$53.91 million.
| Operating Cash Flow | -53.29M |
| Capital Expenditures | -618,000 |
| Free Cash Flow | -53.91M |
| FCF Per Share | -$2.97 |
Full Cash Flow StatementMargins
Gross margin is 37.74%, with operating and profit margins of -57.92% and -73.12%.
| Gross Margin | 37.74% |
| Operating Margin | -57.92% |
| Pretax Margin | -72.61% |
| Profit Margin | -73.12% |
| EBITDA Margin | -53.86% |
| EBIT Margin | -57.92% |
| FCF Margin | n/a |
Dividends & Yields
Outset Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -237.60% |
| Shareholder Yield | -237.60% |
| Earnings Yield | -112.74% |
| FCF Yield | -69.23% |
Analyst Forecast
The average price target for Outset Medical is $16.00, which is 272.96% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $16.00 |
| Price Target Difference | 272.96% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 13.73% |
| EPS Growth Forecast (5Y) | -66.13% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 20, 2025. It was a reverse split with a ratio of 1:15.
| Last Split Date | Mar 20, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
Outset Medical has an Altman Z-Score of -4.47 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.47 |
| Piotroski F-Score | 5 |
